Clinical Trial Update: LONG-DES VI (Drug Eluting Stent for Long Lesions in Coronary Artery) [Phase 4]

View source ↗

Summary

Phase 4 LONG-DES VI trial evaluating a drug-eluting stent for long coronary lesions has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• LONG-DES VI

Snippet

Sponsor: Seung-Jung Park | Conditions: Coronary Artery Disease | Phase 4 | Status: TERMINATED